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*Vibrio cholerae* is a Gram-negative bacterium and the etiologic agent of cholera. Cholera is endemic in regions with poor sanitation and can be a significant problem wherever local infrastructure is disrupted due to natural or human-caused disasters. A recent bulletin of the World Health Organization reported that there are an estimated 2.8 million cases and 91,000 deaths annually due to cholera, with the highest burden being in children under the age of 5 years ([@B1]).

*V. cholerae* strains can be classified into over 200 serogroups on the basis of differences in the surface-expressed O antigen. Typically, cholera epidemics are associated with specific serogroups, namely O1 and O139, although the recent events in Haiti demonstrate an interesting exception ([@B2]). It is currently not known why specific serogroups are associated with epidemic potential even though many other serogroups carry the major virulence factors.

Fifteen clinical isolates of various serogroups from the Sakazaki type strain collection were draft sequenced using the Roche/454 Titanium sequencer (see [Table 1](#tab1){ref-type="table"}). Although all 15 are patient isolates, 13 of them belong to non-O1/non-O139 serogroups.

###### 

Listing of strains with serogroups, original country of isolation, and GenBank accession numbers

  Strain                                        Serogroup   Isolation country   Accession no.
  --------------------------------------------- ----------- ------------------- ------------------------------
  NIH41                                         O1          India               [JIDH00000000](JIDH00000000)
  5473-62                                       O31         Philippines         [JIDI00000000](JIDI00000000)
  1311-69                                       O35         India               [JIDJ00000000](JIDJ00000000)
  133-73                                        O48         India               [JIDK00000000](JIDK00000000)
  1157-74                                       O53         India               [JIDL00000000](JIDL00000000)
  981-75                                        O65         India               [JIDM00000000](JIDM00000000)
  8-76                                          O77         India               [JIDN00000000](JIDN00000000)
  1421-77                                       O80         India               [JMBL00000000](JMBL00000000)
  984-81                                        O89         India               [JMBM00000000](JMBM00000000)
  571-88                                        O105        China               [JIDO00000000](JIDO00000000)
  523-80[^*a*^](#tab1-1){ref-type="table-fn"}   O115        United States       [JIDP00000000](JIDP00000000)
  63-93                                         O139        India               [JMBN00000000](JMBN00000000)
  234-93                                        O141        India               [JMBO00000000](JMBO00000000)
  254-93                                        O144        India               [JMBP00000000](JMBP00000000)
  490-93                                        O155        Thailand            [JIDQ00000000](JIDQ00000000)

*Vibrio mimicus*.

Genomic DNA was extracted using the Wizard kit (Promega, Madison, WI). 454 Titanium libraries were prepared and emulsion PCR (emPCR) was performed per the manufacturer's instructions, prior to multiplexed sequencing and *de novo* assembly. On average, over 500,000 sequencing reads were produced per strain, resulting in genome coverage ranging from 19.4- to 58.4-fold depth.

Preliminary analyses indicate that some of the major *V. cholerae* virulence factors are present in a subset of these genomes. For instance, we identified sequences corresponding to all or a large part of *V. cholerae* pathogenicity island 1 (VPI-1), not only in NIH41 and 63-93 (O1 and O139, respectively), but also in nonepidemic strains 981-75, 1421-77, 571-88, 523-80, and 234-93. We identified sequences with homology to the cholera toxin genes in NIH-41 and 63-93, as expected, as well as in 571-88, 234-93, and 490-93. Finally, we identified sequences corresponding to all or part of VPI-2 in NIH-41 and 981-75. Given that these are draft genomes and in some cases gaps exist within these particular regions, further investigation is required to elucidate whether these virulence factors are functional. These draft genomes have the potential to aid our understanding of virulence and epidemicity in *V. cholerae*. These data contribute to broadening the reference genome collection available for studies aimed at *V. cholerae* genetic diversity and strain attribution.

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

The sequence data were deposited in GenBank under project accession numbers listed in [Table 1](#tab1){ref-type="table"}.

**Citation** Bishop-Lilly KA, Johnson SL, Verratti K, Luu T, Khiani A, Awosika J, Mokashi VP, Chain PSG, Sozhamannan S. 2014. Genome sequencing of 15 clinical *Vibrio* isolates, including 13 non-O1/non-O139 serogroup strains. Genome Announc. 2(5):e00893-14. doi:10.1128/genomeA.00893-14.

We thank Hidemasa Izumiya and the rest of National Institute of Infectious Diseases, Japan, for allowing us to use the strain collection.

This work was supported under contract TMTI_IB06RSQ002 through the Defense Threat Reduction Agency (to S.S.).

The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. Vishwesh Mokashi is an employee of the U.S. Government and this work was prepared as part of his official duties.

[^1]: Present address: Kathleen Verratti, Johns Hopkins Applied Physics Laboratory, Laurel, Maryland, USA; Shanmuga Sozhamannan, Goldbelt Raven, LLC, Frederick, Maryland, USA.
